Fundraising FoxBioGenerator Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Pairidex offers FusionMRD, a personalized digital droplet PCR (ddPCR) assay that detects and quantifies oncogenic gene fusions from a standard peripheral blood sample to monitor treatment response and minimal residual disease in gene fusion-driven blood cancers such as leukemia.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Grant Challen(Co-Founder & Scientific Advisor)inAllyson Mayer(Interim COO)inAndrew Young(Founder & CSO)Paul Kortschak(CEO)in
BoardTodd Druley(Director)
Board seatCrystal Winkeler· per SEC Form D
Co-investorsiSelect Fund
Edison Agro Sciences develops bio-based synthetic rubber from sunflower crops as an alternative to petrochemical and natural rubber for industrial applications.
AgTechBiotechCleantechNew MaterialsSt. Louis, US
David Woodburn(Executive Officer, Director)inMatthew B Crisp(Executive Officer, Director)Thomas Hohn(Executive Officer, Director)inTom Christensen(Executive Officer, Director, Promoter)
BoardDan Broderick(Director)Matt Helms(Director)
Co-investorsArieal Southeast Angel Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.